203 related articles for article (PubMed ID: 23653391)
21. Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents.
Chen G; Xu S; Renko K; Derwahl M
J Clin Endocrinol Metab; 2012 Apr; 97(4):E510-20. PubMed ID: 22278418
[TBL] [Abstract][Full Text] [Related]
22. Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models.
Ponte JF; Ab O; Lanieri L; Lee J; Coccia J; Bartle LM; Themeles M; Zhou Y; Pinkas J; Ruiz-Soto R
Neoplasia; 2016 Dec; 18(12):775-784. PubMed ID: 27889646
[TBL] [Abstract][Full Text] [Related]
23. Optimal chemotherapy treatment for women with recurrent ovarian cancer.
Fung-Kee-Fung M; Oliver T; Elit L; Oza A; Hirte HW; Bryson P
Curr Oncol; 2007 Oct; 14(5):195-208. PubMed ID: 17938703
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
[TBL] [Abstract][Full Text] [Related]
25. Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells.
Dasari VR; Carey DJ; Gogoi R
BMC Cancer; 2020 Apr; 20(1):273. PubMed ID: 32245422
[TBL] [Abstract][Full Text] [Related]
26. Response of primary culture of human ovarian cancer cells to chemotherapy: In vitro individualized therapy.
Kar R; Sharma C; Sen S; Jain SK; Gupta SD; Singh N
J Cancer Res Ther; 2016; 12(2):1050-5. PubMed ID: 27461697
[TBL] [Abstract][Full Text] [Related]
27. The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin.
Witham J; Valenti MR; De-Haven-Brandon AK; Vidot S; Eccles SA; Kaye SB; Richardson A
Clin Cancer Res; 2007 Dec; 13(23):7191-8. PubMed ID: 18056200
[TBL] [Abstract][Full Text] [Related]
28. Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner.
Rattan R; Giri S; Hartmann LC; Shridhar V
J Cell Mol Med; 2011 Jan; 15(1):166-78. PubMed ID: 19874425
[TBL] [Abstract][Full Text] [Related]
29. The impact of novel retinoids in combination with platinum chemotherapy on ovarian cancer stem cells.
Whitworth JM; Londoño-Joshi AI; Sellers JC; Oliver PJ; Muccio DD; Atigadda VR; Straughn JM; Buchsbaum DJ
Gynecol Oncol; 2012 Apr; 125(1):226-30. PubMed ID: 22155260
[TBL] [Abstract][Full Text] [Related]
30. Metformin targets ovarian cancer stem cells in vitro and in vivo.
Shank JJ; Yang K; Ghannam J; Cabrera L; Johnston CJ; Reynolds RK; Buckanovich RJ
Gynecol Oncol; 2012 Nov; 127(2):390-7. PubMed ID: 22864111
[TBL] [Abstract][Full Text] [Related]
31. Alofanib, an allosteric FGFR2 inhibitor, has potent effects on ovarian cancer growth in preclinical studies.
Tyulyandina A; Harrison D; Yin W; Stepanova E; Kochenkov D; Solomko E; Peretolchina N; Daeyaert F; Joos JB; Van Aken K; Byakhov M; Gavrilova E; Tjulandin S; Tsimafeyeu I
Invest New Drugs; 2017 Apr; 35(2):127-133. PubMed ID: 27812884
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Effects of Metformin in Primary Ovarian Cancer Cells.
Patel S; Singh N; Kumar L
Asian Pac J Cancer Prev; 2015; 16(16):6973-9. PubMed ID: 26514477
[TBL] [Abstract][Full Text] [Related]
33. Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types.
Iliopoulos D; Hirsch HA; Struhl K
Cancer Res; 2011 May; 71(9):3196-201. PubMed ID: 21415163
[TBL] [Abstract][Full Text] [Related]
34. A systematic overview of chemotherapy effects in ovarian cancer.
Högberg T; Glimelius B; Nygren P;
Acta Oncol; 2001; 40(2-3):340-60. PubMed ID: 11441940
[TBL] [Abstract][Full Text] [Related]
35. Effect of TRA-8 anti-death receptor 5 antibody in combination with chemotherapy in an ex vivo human ovarian cancer model.
Frederick PJ; Kendrick JE; Straughn JM; Della Manna DL; Oliver PG; Lin HY; Grizzle WE; Stockard CR; Alvarez RD; Zhou T; LoBuglio AF; Buchsbaum DJ
Int J Gynecol Cancer; 2009 Jul; 19(5):814-9. PubMed ID: 19574765
[TBL] [Abstract][Full Text] [Related]
36. [Combinative effects of FAP-1 antisense oligonucleotide and carboplatin on apoptosis of ovarian cancer cell SKOV3].
Wang B; Zheng WG; Xin XY; Qi RY; Yu YC; Cao YX
Ai Zheng; 2004 Aug; 23(8):885-9. PubMed ID: 15301708
[TBL] [Abstract][Full Text] [Related]
37. Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS).
Au-Yeung G; Webb PM; DeFazio A; Fereday S; Bressel M; Mileshkin L
Gynecol Oncol; 2014 Apr; 133(1):16-22. PubMed ID: 24680586
[TBL] [Abstract][Full Text] [Related]
38. Effect of near field ultrasound on carboplatin treatment of ovarian carcinoma cells.
Bernard V; Mornstein V; Bourek A
Indian J Biochem Biophys; 2013 Aug; 50(4):284-8. PubMed ID: 24772947
[TBL] [Abstract][Full Text] [Related]
39. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
[TBL] [Abstract][Full Text] [Related]
40. Efficacious dose of metformin for breast cancer therapy is determined by cation transporter expression in tumours.
Cai H; Everett RS; Thakker DR
Br J Pharmacol; 2019 Aug; 176(15):2724-2735. PubMed ID: 31032880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
